|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Genous endothelial progenitor cell-capturing stent system: a novel stent technology显示文摘 | Klomp M Beijk MA de Winter RJ | 2009 | Ex pert Rev Med Devices2009，6，4： | 1 |
| 2 | A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the set- ting of acute myocardial infarction显示文摘 | Vis MM Beijk MA Grundeken M J | 2013 | Jacc Cardiovascular Interven- tions2013，6，4： | 1 |
| 3 | XIENCE V everolimus - eluting coronary stent system : a novel second generation drug-eluting stent 显示文摘 | Beijk MA Piek JJ | 2007 | Expert Rev Med Devices2007，4，1： | 1 |
| 4 | Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis显示文摘 | Woudstra P Damman P Beijk MA | 2013 | Catheter Cardiovasc Interv2013，81，： | 1 |
| 5 | XIENCE V everolimus -eluting coronary stent system: a novel second generation drug-eluting stent 显示文摘 | Beijk MA Piek JJ | 2007 | Expert Rev Med Devices2007，4，1： | 1 |
| 6 | Clinical outcomes afterPercutaneous or surgical revascularisation of unprotected left main coronary artery-related acute myocardial infarction:a singlecentre experience显示文摘 | Grundeken M J Vis MM Beijk MA | | 0，，： | 1 |
| 7 | XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent显示文摘 | Beijk MA Piek JJ | 2007 | Expert Rev Med Devices2007，4，1： | 1 |
| 8 | Two-year Iol- low-up of the GenousTM endothelial progenitor cell cap- turing stent versus the Taxus Libertstent in patients with de novo coroenary artery lesions with a high-risk of rest- enosis : A randomized, single-center, pilot study显示文摘 | Beijk MA Klomp M van Geloven N | 2011 | Cathe- ter Cardiovasc Interv2011，78，2： | 1 |
| 9 | 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter,randomized trial comparing ge- nous endothelial progenitor cell capturing stents with drug-eluting stents 显示文摘 | Klomp M Beijk MA Varma C | 2011 | JACC Cardiovasc Interv2011，4，8： | 1 |
| 10 | Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native cor- onary arterylesions: the SPIRIT II trial 显示文摘 | Claessen BE Beijk MA Legrand V | 2009 | Circ Cardiovasc Interv2009，2，4： | 1 |
| 11 | Three-year clinical follow-up of an unselected patient population treated with the genous endothe- lial progenitor cell capturing stent显示文摘 | Klomp M Beijk MA Damman P | 2011 | J Interv Cardiol2011，24，5： | 1 |
| 12 | Individuals at in- creased coronary heart disease risk are characterized by an impaired microvascular function in skin 显示文摘 | Ijzerman RG de Jongh RT Beijk MA | 2003 | Eur J Clin Invest2003，33，7： | 1 |
| 13 | Two-year clinical,angiographic,and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions:the SPIRIT Ⅱ trial显示文摘 | Claessen BE Beijk MA Legrand V | | 0，，04： | 1 |
| 14 | XIENCE V everolimus-eluting coronary stent system: a novel second Generation drug-eluting stent 显示文摘 | Beijk MA Piek JJ | 2007 | Expert Rev Med Devices2007，4，1： | 1 |
| 15 | 1-yearoutcomeofTRIAS HR (TRIstent adjudication studyhigh risk ofrestenosis)amulticenter,randomizedtrialcomparinggenousendothelialprogenitorcellcapturingstentswithdrugelutingstents显示文摘 | Klomp M Beijk MA VarmaC etal | 2011 | JACCCardiovascInterv2011，4，8： | 1 |
| 16 | Two-year follow-up of the GenousTM endothelial progenitor cell capturing stent versus the Taxus Liberte stent in patients with de novo coronary artery lesions with a high-risk of restenosis : a ran- domized, single-center, pilot study 显示文摘 | Beijk MA Klomp M van Geloven N | 2011 | Catheter Cardiovasc Interv2011，78，2： | 1 |
| 17 | Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent 显示文摘 | Klomp M Beijk MA Damman P | 2011 | J Interv Cardiol2011，24，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员